Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169 in Thai Healthy Volunteers
TCTR20220706004Phase 0Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- Aug 2022
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 0, single-arm trial of rDEN2Δ30-7169 in dengue fever, sponsored by Siriraj Hospital. Primary endpoints: Safety assessment, Virological assessment and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
rDEN2Δ30-7169
03
Conditions
dengue fever
Beyond the preview
Go deeper on TCTR20220706004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220706004.